Brought to you by 
IRhythm Technologies brings in $6.7mm through its Series C venture round; adds $7mm
20 Oct 2011
Executive Summary
One year after completing its $10mm Series B financing, iRhythm Technologies Inc. (diagnostic monitoring devices) has raised $6.7mm through its Series C venture round. According to the Form D, an additional $8.3mm is expected. New investor New Leaf Venture Partners led (and contributes a board member) and was joined by current backers Mohr Davidow Ventures, Synergy Life Science Partners, St. Jude Medical, and other three other undisclosed shareholders. The company will use the proceeds to market its Zio patch, an ambulatory cardiac rhythm monitor that can be used for up to two weeks.
Deal Industry
- Medical Devices
-
Medical Devices
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
IRhythm Technologies brings in $6.7mm through its Series C venture round; adds $7mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice